Although systemic amyloidosis of amyloid-associated protein (AA) type (secondary or reactive amyloidosis) frequently involves the liver, it rarely causes clinically apparent liver disease. Mild elevation of alkaline phosphatase and hepatomegaly are the most common biochemical and clinical findings, respectively. We report a case of systemic amyloidosis of AA type, which clinically presented as subacute hepatic failure and resulted in a fatal clinical course in a 69-year-old man. To the best of our knowledge, this is the fifth case of hepatic amyloidosis of AA type that clinically presented as fatal subacute hepatic failure, an unusual clinical presentation for hepatic involvement by systemic AA-type amyloid.
CITATION STYLE
Altraif, I., Handoo, F. A., Alsaad, K. O., & Gublan, A. (2010). Fatal Subacute Hepatic Failure in a Patient with AA-Type Amyloidosis: Case Report. Pathology Research International, 2010, 1–4. https://doi.org/10.4061/2010/648089
Mendeley helps you to discover research relevant for your work.